CSL Limited (CSLLY) Financials

CSLLY Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 25.4 billion 12.4 billion
June 30, 2023 24.0 billion 12.2 billion
March 31, 2023 36.4 billion 18.5 billion
Dec. 31, 2022 24.1 billion 12.0 billion

CSLLY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 250.0 million ?
June 30, 2023 479.3 million 36.7 million
March 31, 2023 483.1 million 36.9 million
Dec. 31, 2022 205.4 million 32.7 million

CSLLY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2023 1.3 billion
June 30, 2023 284.3 million
March 31, 2023 286.5 million
Dec. 31, 2022 812.1 million

CSLLY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 692.9 million - -
June 30, 2023 1.0 billion - 1.1 billion
March 31, 2023 1.6 billion - -
Dec. 31, 2022 1.0 billion - -

CSLLY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 660.8 million
June 30, 2023 643.0 million
March 31, 2023 324.9 million
Dec. 31, 2022 658.9 million

CSLLY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 478.3 million 456.5 million - -
June 30, 2023 327.8 million 435.0 million 250.2 million 391.2 million
March 31, 2023 330.3 million 330.5 million 252.1 million 394.2 million
Dec. 31, 2022 285.1 million 392.7 million 200.0 million 334.5 million

CSLLY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 5.5 billion 2.7 billion
June 30, 2023 4.0 billion 2.2 billion
March 31, 2023 3.1 billion 1.6 billion
Dec. 31, 2022 4.9 billion 2.4 billion

CSLLY

Price: $16.35

52 week price:
16.35
44.86

Dividend Yield: 3.26%

5-year range yield:
1.01%
3.26%

Forward Dividend Yield: 3.98%

Payout Ratio: 43.75%

Dividend Per Share: 0.65 USD

Earnings Per Share: 3.08 USD

P/E Ratio: 8.20

Exchange: OQX

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Market Capitalization: 86.7 billion

Average Dividend Frequency: 2

Years Paying Dividends: 18

DGR3: 7.49%

DGR5: 7.64%

DGR10: 9.40%

Links: